Primarily D2C cash-pay

D2C telehealth platform spanning weight loss, primary care, sexual health, hair, skin, and mental health. Weight loss includes oral kits, GLP-1 support, app-based care, and prescription management.

Mar 13, 2026

D2C cash-pay membership; insurance concierge for medication coverage

D2C telehealth company with services in weight loss (Ro Body), sexual health, fertility, skin, and primary care. Includes insurance concierge, labs, coaching, and medication management.

Mar 13, 2026

D2C, employer, health plan, and provider referral channels. Available in most U.S. states via telehealth.

Virtual obesity medicine clinic with 1:1 care from board-certified obesity medicine (ABOM) physicians, nurse practitioners, physician assistants, and registered dietitians. Uses a science-based care model with behavior change, nutrition, physical activity, and FDA-approved medication when appropriate. Prescribes branded GLP-1 medications including Wegovy and Zepbound.

Mar 13, 2026

Mostly via employers, payers, health systems, and PBMs; some direct patient pathways through sponsored programs

Virtual-first cardiometabolic solution for obesity and related conditions (prediabetes/diabetes, hypertension, hyperlipidemia). Uses multidisciplinary care, precision pharmacotherapy, and digital engagement.

Mar 13, 2026

Primarily D2C; supports both insurance and cash-pay medication pathways

Behavior-change weight-loss platform with Noom Med / GLP-1 Rx programs, clinician access, habit-change tools, community features, and medication support integrated into the Noom app.

Mar 13, 2026

D2C for individuals plus employers, health plans, and PBMs

Whole-body cardiometabolic care for weight loss, diabetes, and heart health. Offers specialists, pharmacists, dietitians, labs, medications, connected devices, and ongoing virtual support.

Mar 13, 2026

Direct patient care via insurance or self-pay; in-person clinics in select markets plus virtual care; payer partnerships

Weight-inclusive obesity medicine plus primary care delivered by primary care physicians, obesity medicine specialists, nurse practitioners, and registered dietitians. Offers nutrition support, teens care, and both virtual and in-person visits. Positioned as an integrated obesity medicine + PCP hybrid rather than meds-only telehealth.

Mar 13, 2026

Primarily D2C; also works with insurance for medication/care coverage and some employer channels

Longstanding digital + community weight-management brand now offering WW Clinic / Med+ memberships for prescription weight-loss medications, insurance coordination, nutrition tools, and GLP-1 support inside the WW app. WW Clinic is powered by Sequence, the telehealth weight-management platform WeightWatchers acquired in 2023. Sequence is no longer independently accessible; patients access its clinical infrastructure through WW Clinic.

Mar 13, 2026

Mostly through employers, health plans, providers, and other sponsors

Broad virtual care company spanning urgent care, primary care, mental health, chronic condition programs, and sponsor-based weight management. Weight-loss programs can include coaching and medication support including GLP-1s when appropriate.

Mar 13, 2026

Mostly through employers, health plans, and health systems

Virtual chronic-care platform with weight health, GLP-1 companion programs, diabetes, hypertension, MSK, and behavior-change support. Strong B2B distribution with integrated care journeys.

Mar 13, 2026

D2C nationwide in all 50 states; some in-network / Wellness Plus pathways

Telehealth obesity clinic available in all 50 states. Offers board-certified providers, dietitians, app-based care, direct messaging, and both branded and compounded GLP-1 medications including compounded semaglutide and compounded tirzepatide.

Mar 13, 2026

D2C and employer-sponsored programs

Clinician-guided metabolic health program structured as a 1-year commitment with GLP-1 prescribing, labs, 1:1 coaching, app-based tracking, and behavior change. The clinical protocol goes beyond GLP-1 prescribing alone but centers on medication-supported metabolic improvement rather than a nutrition-only or surgery-based model. Prescribes FDA-approved GLP-1s including Wegovy and Zepbound, plus oral GLP-1 options. Sells to consumers and employers.

Mar 13, 2026

D2C plus expanding employer channel; supports both self-pay and in-network pathways in some markets

Personalized metabolic care program combining obesity-trained clinicians, behavior-change tools, community, and a broad medication toolkit including GLP-1 and non-GLP-1 options.

Mar 13, 2026

Primarily employer and health-plan benefit channel

Enterprise virtual obesity and chronic-condition care with coaching, therapists, dietitians, medical providers, and anti-obesity medication management including GLP-1s.

Mar 13, 2026

Primarily employers and health plans; some individual access pathways

Nutrition-first virtual metabolic care company focused on weight loss, type 2 diabetes reversal/remission, and reducing dependence on costly medications. Virta's model differs from most companies in this directory in a specific way: it leads with a nutrition-based intervention (typically very-low-carbohydrate) and positions GLP-1 medications as a complement or off-ramp rather than the primary treatment. Patients who want or need GLP-1s can access them, but the clinical philosophy centers on reducing medication dependence over time. Offers care teams, app, and structured nutritional therapy.

Mar 13, 2026

Primarily D2C cash-pay

National D2C telehealth provider offering online primary care, urgent care, mental health, sexual health, and weight-loss memberships with medication delivery support.

Mar 13, 2026